{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:08:34Z","timestamp":1779916114694,"version":"3.53.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","interventional.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.iccl.2026.03.010","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:52:47Z","timestamp":1777060367000},"page":"445-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing Anticoagulation Therapy when Utilizing Mechanical Circulatory Support Devices"],"prefix":"10.1016","volume":"15","author":[{"given":"Maurizio","family":"Bertaina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Franchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"G\u0105secka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.iccl.2026.03.010_bib1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.2020.0254","article-title":"Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with In-Hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock","volume":"323","author":"Dhruva","year":"2020","journal-title":"JAMA"},{"issue":"suppl_1","key":"10.1016\/j.iccl.2026.03.010_bib2","article-title":"126High-output mechanical circulatory support devices for cardiogenic shock after myocardial infarction: ECMO versus Impella CP\/5.0","volume":"39","author":"Karami","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2026.03.010_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijcard.2020.09.044","article-title":"Short term outcomes of Impella in cardiogenic shock: a review and meta-analysis of observational studies","volume":"324","author":"Iannaccone","year":"2021","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.iccl.2026.03.010_bib4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jcin.2020.02.042","article-title":"Frequency and impact of bleeding on outcome in patients with cardiogenic shock","volume":"13","author":"Freund","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.iccl.2026.03.010_bib5","first-page":"1129","article-title":"Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock","volume":"97","author":"Pahuja","year":"2021","journal-title":"Cathet Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.iccl.2026.03.010_bib6","first-page":"458","article-title":"European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: a survey of the Association for Acute CardioVascular Care of the ESC and the European branch of the Extracorporeal Life Support Organization","volume":"13","author":"Van Edom","year":"2024","journal-title":"Eur Heart J: Acute Cardiovascular Care"},{"issue":"4","key":"10.1016\/j.iccl.2026.03.010_bib7","first-page":"392","article-title":"Haematological challenges in cardiogenic shock","volume":"29","author":"Van Edom","year":"2023","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"10.1016\/j.iccl.2026.03.010_bib8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/hematology.2023000502","article-title":"Consumptive coagulopathy in the ICU","volume":"2023","author":"Retter","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.iccl.2026.03.010_bib9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1055\/a-1508-8230","article-title":"Optimal tests to minimise bleeding and ischaemic complications in patients on extracorporeal membrane oxygenation","volume":"122","author":"Kanji","year":"2022","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.iccl.2026.03.010_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00134-019-05897-3","article-title":"Why we need safer anticoagulant strategies for patients on short-term percutaneous mechanical circulatory support","volume":"46","author":"Vandenbriele","year":"2020","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.iccl.2026.03.010_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/ALN.0000000000004980","article-title":"Fibrinolysis as a causative mechanism for bleeding complications on extracorporeal membrane oxygenation: a pilot observational prospective Study","volume":"141","author":"Helms","year":"2024","journal-title":"Anesthesiology"},{"issue":"Supplement_2","key":"10.1016\/j.iccl.2026.03.010_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.1538","article-title":"Acquired von Willebrand Syndrome in left Impella supported cardiogenic shock patients","volume":"41","author":"Vandenbriele","year":"2020","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.iccl.2026.03.010_bib13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jchf.2015.06.016","article-title":"Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding","volume":"3","author":"Bartoli","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"Supplement_2","key":"10.1016\/j.iccl.2026.03.010_bib14","doi-asserted-by":"crossref","first-page":"ehaa946","DOI":"10.1093\/ehjci\/ehaa946.3836","article-title":"Inhibition of adamts13: a novel therapy to treat mechanical circulatory support-induced acquired von willebrand syndrome","volume":"41","author":"Deconinck","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.iccl.2026.03.010_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MAT.0000000000000290","article-title":"Incidence of hemolysis in patients with cardiogenic shock treated with Impella Percutaneous left ventricular assist device","volume":"62","author":"Badiye","year":"2016","journal-title":"ASAIO J"},{"issue":"2","key":"10.1016\/j.iccl.2026.03.010_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/aor.13319","article-title":"Increased plasma-free hemoglobin levels identify hemolysis in patients with cardiogenic shock and a Trans valvular micro-axial flow pump","volume":"43","author":"Esposito","year":"2019","journal-title":"Artif Organs"},{"issue":"8","key":"10.1016\/j.iccl.2026.03.010_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2020.03.010","article-title":"Updated definitions of adverse events for trials and registries of mechanical circulatory support: a consensus statement of the mechanical circulatory support academic research consortium","volume":"39","author":"Kormos","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.iccl.2026.03.010_bib18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/j.ajkd.2008.07.012","article-title":"Induction of heme oxygenase-1 and ferritin in the kidney in warm antibody hemolytic anemia","volume":"52","author":"Fervenza","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.iccl.2026.03.010_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/aor.14099","article-title":"Initial experience with CytoSorb therapy in patients receiving left ventricular assist devices","volume":"46","author":"Zhigalov","year":"2022","journal-title":"Artif Organs"},{"issue":"1","key":"10.1016\/j.iccl.2026.03.010_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ehf2.15087","article-title":"Impella malrotation affects left ventricle unloading in cardiogenic shock patients","volume":"12","author":"Baldetti","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.iccl.2026.03.010_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/0391398820909843","article-title":"Hemolysis associated with Impella heart pump positioning: in vitro hemolysis testing and computational fluid dynamics modeling","author":"Roberts","year":"2020","journal-title":"Int J Artif Organs"},{"issue":"8","key":"10.1016\/j.iccl.2026.03.010_bib22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00392-018-1230-6","article-title":"Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial impella\u00ae pump: results from the German impella\u00ae registry","volume":"107","author":"Baumann","year":"2018","journal-title":"Clin Res Cardiol"},{"issue":"15","key":"10.1016\/j.iccl.2026.03.010_bib23","doi-asserted-by":"crossref","first-page":"e1343","DOI":"10.4244\/EIJ-D-19-00428","article-title":"Observational multicentre registry of patients treated with IMPella mechanical circulatory support device in ITaly: the IMP-IT registry","volume":"15","author":"Chieffo","year":"2020","journal-title":"EuroIntervention"},{"issue":"5","key":"10.1016\/j.iccl.2026.03.010_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1253\/circj.CJ-22-0476","article-title":"Short-term outcomes of impella support in Japanese patients with cardiogenic shock due to acute myocardial infarction - japanese registry for percutaneous ventricular assist device (J-PVAD)","volume":"87","author":"Ikeda","year":"2023","journal-title":"Circ J"},{"key":"10.1016\/j.iccl.2026.03.010_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ahj.2017.09.007","article-title":"The cVAD registry for percutaneous temporary hemodynamic support: a prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure","volume":"199","author":"Vetrovec","year":"2018","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.iccl.2026.03.010_bib26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.33963\/v.kp.97218","article-title":"Multicenter registry of Impella-assisted high-risk percutaneous coronary interventions and cardiogenic shock in Poland (IMPELLA-PL)","volume":"81","author":"Pietrasik","year":"2023","journal-title":"Kardiol Pol"},{"issue":"2","key":"10.1016\/j.iccl.2026.03.010_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jjcc.2021.08.011","article-title":"Incidence, predictors, and clinical outcomes of mechanical circulatory support-related complications in patients with cardiogenic shock","volume":"79","author":"Takahashi","year":"2022","journal-title":"J Cardiol"},{"issue":"4","key":"10.1016\/j.iccl.2026.03.010_bib28","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/ehf2.14397","article-title":"Roadmap towards an institutional Impella programme for high-risk coronary interventions","volume":"10","author":"Pietrasik","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.iccl.2026.03.010_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.carrev.2024.07.005","article-title":"Peripheral intravascular lithotripsy to facilitate transfemoral transcatheter aortic valve replacement - defining optimal treatable peripheral arterial disease burden","volume":"73","author":"Tom","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"issue":"1","key":"10.1016\/j.iccl.2026.03.010_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54277-w","article-title":"Access site complications following Impella-supported high-risk percutaneous coronary interventions","volume":"9","author":"Johannsen","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.iccl.2026.03.010_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.010742","article-title":"Ultrasound- versus fluoroscopy-guided strategy for transfemoral transcatheter aortic valve replacement access: a systematic review and meta-analysis","volume":"14","author":"Kotronias","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.iccl.2026.03.010_bib32","article-title":"A new iteration for the single-access large-bore technique during Impella supported complex and high-risk coronary intervention: a case report","volume":"5","author":"Araco","year":"2021","journal-title":"Eur Heart J Case Rep"},{"issue":"15","key":"10.1016\/j.iccl.2026.03.010_bib33","doi-asserted-by":"crossref","first-page":"e1558","DOI":"10.4244\/EIJ-D-18-00769","article-title":"Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide","volume":"14","author":"Moriyama","year":"2019","journal-title":"EuroIntervention"},{"issue":"11","key":"10.1016\/j.iccl.2026.03.010_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.42361","article-title":"Anemia acuity effect on transfusion strategies in acute myocardial infarction: a secondary analysis of the MINT trial","volume":"7","author":"Carrier","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.iccl.2026.03.010_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1429900","article-title":"Implications of anemia in patients undergoing PCI with Impella-support: insights from the PROTECT III study","volume":"11","author":"Falah","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.iccl.2026.03.010_bib36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11239-019-01837-6","article-title":"Management of anticoagulation with impella\u00ae percutaneous ventricular assist devices and review of new literature","volume":"48","author":"Succar","year":"2019","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"10.1016\/j.iccl.2026.03.010_bib37","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1053\/j.jvca.2024.08.010","article-title":"Hemocompatibility-related adverse events in patients with temporary mechanical circulatory support: the scoring haemostasis events and assessment for risk (SHEAR) score","volume":"38","author":"Pappalardo","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"6","key":"10.1016\/j.iccl.2026.03.010_bib38","first-page":"458","article-title":"European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: a survey of the Association for Acute CardioVascular Care of the ESC and the European branch of the Extracorporeal Life Support Organization","volume":"13","author":"Van Edom","year":"2024","journal-title":"Eur Heart J: Acute Cardiovascular Care"},{"key":"10.1016\/j.iccl.2026.03.010_bib39","first-page":"2021","article-title":"Monitoring unfractionated heparin in adult patients undergoing extracorporeal membrane oxygenation (ECMO): ACT, APTT, or ANTI-XA?","author":"Nguyen","year":"2021","journal-title":"Critical Care Research and Practice"},{"key":"10.1016\/j.iccl.2026.03.010_bib40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00134-014-3574-3","article-title":"Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation","volume":"41","author":"Chu","year":"2015","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.iccl.2026.03.010_bib41","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/MAT.0000000000001334","article-title":"Heparin resistance is common in patients undergoing extracorporeal membrane oxygenation but is not associated with worse clinical outcomes","volume":"67","author":"Raghunathan","year":"2021","journal-title":"ASAIO J"},{"issue":"19","key":"10.1016\/j.iccl.2026.03.010_bib42","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2022.02.052","article-title":"Anticoagulation for percutaneous ventricular assist device-supported cardiogenic shock: JACC review topic of the week","volume":"79","author":"Vandenbriele","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2026.03.010_bib43","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jtha.2025.02.028","article-title":"Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock","volume":"23","author":"Van Edom","year":"2025","journal-title":"J Thromb Haemostasis"},{"issue":"14","key":"10.1016\/j.iccl.2026.03.010_bib44","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jcin.2023.05.043","article-title":"Management of bleeding and hemolysis during percutaneous microaxial flow pump support: a practical approach","volume":"16","author":"Van Edom","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.iccl.2026.03.010_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s12959-024-00624-5","article-title":"Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis","volume":"22","author":"Song","year":"2024","journal-title":"Thromb J"},{"issue":"12","key":"10.1016\/j.iccl.2026.03.010_bib46","first-page":"161","article-title":"Heparin-induced thrombocytopenia under mechanical circulatory support by large impella for acute cardiogenic shock","volume":"8","author":"Sugimura","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"issue":"2","key":"10.1016\/j.iccl.2026.03.010_bib47","first-page":"318","article-title":"Incidence and severity of thrombocytopenia associated with use of intravascular microaxial ventricular assist devices for treatment of cardiogenic shock","volume":"101","author":"Goetz","year":"2023","journal-title":"Cathet Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.iccl.2026.03.010_bib48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 t\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemostasis"},{"issue":"7","key":"10.1016\/j.iccl.2026.03.010_bib49","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1053\/j.jvca.2022.02.030","article-title":"The predictive value of the 4Ts and HEP score at recommended cutoffs in patients with mechanical circulatory support devices","volume":"36","author":"Kram","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.iccl.2026.03.010_bib50","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Clinical platelet disorders heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745826000234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745826000234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:32:59Z","timestamp":1779913979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745826000234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2211745826000234"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2026.03.010","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing Anticoagulation Therapy when Utilizing Mechanical Circulatory Support Devices","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2026.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}